ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01885208
Brief Title: Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes (SUSTAIN™ 3)

First Submitted : June 20, 2013
First Submitted that Met QC Criteria : June 21, 2013
First Posted : June 24, 2013 (Estimate)

Results First Submitted : December 21, 2017
Results First Submitted that Met QC Criteria : March 2, 2018
Results First Posted : March 30, 2018

Certification/Extension First Submitted : September 23, 2016
Certification/Extension First Submitted that Met QC Criteria : September 23, 2016
Certification/Extension First Posted : September 26, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 9, 2018
Last Update Posted : June 7, 2018